These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2465230)

  • 1. Depletion of fibrinolysis activators as a result of continuous stress.
    Lyutova LV; Andreenko GV; Karabasova MA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):356-60. PubMed ID: 2465230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depression of fibrinolysis in long-term stress in the rat].
    Andreenko GV; Liutova LV; Nemchikova A; Karabasova MA; Ustinova EE
    Kardiologiia; 1987 Jul; 27(7):95-9. PubMed ID: 3656929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Animal experiments to determine the toxicity of mercury(II)-chloride in hemostasis].
    Klöcking HP; Meerbach W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):134-44. PubMed ID: 2439414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of single chain pro-UK on the initiation and regulation of fibrinolysis].
    Arimura H; Kasai S; Nishida M; Suyama T
    Rinsho Byori; 1989 Apr; Spec No 81():107-17. PubMed ID: 2502639
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
    Andreenko GV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrinolysis after intraduodenal administration of urokinase in rats.
    Sumi H; Seiki M; Morimoto N; Tsushima H; Maruyama M; Mihara H
    Enzyme; 1985; 33(3):122-7. PubMed ID: 4054071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y; Scully MF; Ellis V; Kakkar VV
    Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasminogen activators and their physiological role].
    Andreenko GV
    Ukr Biokhim Zh (1978); 1983; 55(3):329-43. PubMed ID: 6346623
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reactions of lipid peroxidation and haemostasis in various organs in acute emotional-pain stress].
    Mishchenko IV
    Fiziol Zh (1994); 2002; 48(6):66-9. PubMed ID: 12577472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of the vascular plasminogen activator from the pig ear.
    Klöcking HP; Astedt B; Gerlach D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):851-61. PubMed ID: 6083962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia].
    Astedt B; Fagner U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA].
    Ieko M
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of venous stasis on vessel wall fibrinolysis.
    Stenberg B; Bylock A; Risberg B
    Thromb Haemost; 1984 Apr; 51(2):240-2. PubMed ID: 6539959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.